Health ❯ Healthcare

Regulatory Agencies

FDA Anvisa MHRA European Medicines Agency Food and Drug Administration Drug Approval Process ANSM Drug Safety ANMAT Drug Approval

CHMP Recommends Adding Oral Wegovy Tablets to EU Approval

European Commission approval would create the first oral GLP‑1 for adult weight management with pricing left to EU Member States.

Pharmacal Recalls One Lot of MG217 Eczema Cream Over Staph Contamination

Makary Resigns as FDA Commissioner With Diamantas as Acting Leader

Reports Say Trump Signs Off on Plan to Remove FDA Chief Marty Makary

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

FDA Clears Vepdegestrant, First PROTAC Cancer Drug, for ESR1‑Mutated Breast Cancer

FDA Launches First Real-Time Clinical Trial Pilot With AstraZeneca and Amgen

Brazil Bans All Medicines With Clobutinol Over Cardiac Risk

Recall Issued for Three Napralief Batches Over Missing Dosing and Safety Information

Anvisa Approves Mounjaro for Type 2 Diabetes in Children Ages 10–17

UK Orders Class 2 Recall of Ramipril 10mg Batch Over Mispacked 5mg Strips

Anvisa Bans Gluconex and Tirzedral, Creates Groups to Police Weight-Loss Pens

UK Regulators Approve Single-Dose 7.2mg Wegovy Pen for Weekly Use

FDA Elevates Nationwide Cough-Drop Recall to Class II

Anvisa Rejects Three Semaglutide and Liraglutide Drug Filings in Brazil

Australia Begins Permanently Listing Health Practitioners’ Sexual Misconduct on Public Register

Brazil Cracks Down on Illegal GLP-1 Weight‑Loss Injections as Anvisa Tightens Oversight

FDA Flags Recall of 3.1 Million Store-Brand Eye Drops Over Sterility Concerns

3.1 Million Bottles of Store-Brand Eye Drops Recalled for Sterility Concerns

Fiocruz Flags Rising Influenza A and Severe Respiratory Cases Across Brazil